2004
DOI: 10.2174/1570180043398821
|View full text |Cite
|
Sign up to set email alerts
|

A Stereospecific Route for the Preparation of Trans-Combretastatin Analogs: Synthesis and Cytotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…This outcome is interesting given the varied potencies observed in cis and trans analogues of medicinally important stilbenes such as resveratrol 25 and combretastatin. 26 …”
Section: Biological Results and Discussionmentioning
confidence: 99%
“…This outcome is interesting given the varied potencies observed in cis and trans analogues of medicinally important stilbenes such as resveratrol 25 and combretastatin. 26 …”
Section: Biological Results and Discussionmentioning
confidence: 99%
“…6 Its anticancer effects have been noted in a wide variety of tumor cells. 2,3,[7][8][9][10][11][12] The in vitro antineoplastic potency of MR-4 was found to be higher than that of resveratrol. 3,7,10,11 Interestingly, the antiproliferative activity of MR-4 was more specific to transformed cells than to normal cells.…”
Section: ' Introductionmentioning
confidence: 94%
“…trans -3,4,5,4′-Tetramethoxystilbene (MR-4, also reported as DMU-212) , ( 2 , Figure ) is a resveratrol analogue present in the leaves of Piper caninum . Its anticancer effects have been noted in a wide variety of tumor cells. ,, The in vitro antineoplastic potency of MR-4 was found to be higher than that of resveratrol. ,,, Interestingly, the antiproliferative activity of MR-4 was more specific to transformed cells than to normal cells. ,, Besides its anticancer effects, MR-4 also displayed anti-inflammatory potential. , It suppressed tumor necrosis factor-α-induced activation of transcription factor nuclear factor-κB and inhibited both cyclooxygenases-1 and -2 . Clearly, MR-4 has emerged as a promising candidate for further therapeutic exploration.…”
Section: Introductionmentioning
confidence: 99%